Publications by authors named "M Slim"

There is a growing interest in the use of webcams to conduct eye-tracking experiments over the internet. We assessed the performance of two webcam-based eye-tracking techniques for behavioral research: manual annotation of webcam videos () and the automated WebGazer eye-tracking algorithm. We compared these methods to a traditional infrared eye-tracker and assessed their performance in both lab and web-based settings.

View Article and Find Full Text PDF
Article Synopsis
  • Motor impairments are common after childhood arterial ischemic stroke (C-AIS), affecting the understanding of how these impairments relate to intellectual abilities in children.
  • A study of 34 children with C-AIS found that motor functioning in early recovery significantly correlates with various intellectual skills, including verbal and perceptual reasoning abilities.
  • The results suggest that early motor deficits may influence intellectual development due to neuroplastic changes after injury, while motor functions assessed closer to testing reflect recovery and improvement potentially aided by interventions.
View Article and Find Full Text PDF
Article Synopsis
  • A study developed and validated an AI tool for automatically segmenting the pulp cavity of mandibular molars from cone-beam CT images, dividing data into training, validation, and testing sets for evaluation.
  • The AI tool demonstrated high accuracy in segmentation, with Dice similarity coefficients of 88% for first molars and 90% for second molars, while also significantly reducing time needed for segmentation compared to manual methods.
  • This AI-driven method can enhance efficiency in endodontic procedures by providing quick, accurate 3D models, potentially improving patient outcomes and anticipating complications.
View Article and Find Full Text PDF
Article Synopsis
  • Novel therapies are changing how endometrial cancer (EC) is treated, with a systematic review assessing first-line treatments for advanced or recurrent cases.
  • The review included 108 records from 57 trials, showing varied results with median progression-free survival between 1.9 to 18.8 months and overall survival from 6.9 to 41 months.
  • Concerns about adverse events from conventional treatments suggest that while efficacy is suboptimal, the promising safety and effectiveness of immunotherapies could significantly alter EC management moving forward.
View Article and Find Full Text PDF

Objectives: Sepsis is an evolving process and proposed subtypes may change over time. We hypothesized that previously established sepsis subtypes are dynamic, prognostic of outcome, and trajectories are associated with host response alterations.

Design: A secondary analysis of two observational critically ill sepsis cohorts: the Molecular diAgnosis and Risk stratification of Sepsis (MARS) and the Medical Information Mart for Intensive Care-IV (MIMIC-IV).

View Article and Find Full Text PDF